Neola® obtains CB certification and meets partial regulatory requirements for market approval in the USA

Jun 4, 2024

Press communication Lund, Sweden, June 4, 2024 This is a translation of the Swedish press release published 2024-06-04 Neola Medical AB (publ) announced today that Neola®, the company’s medical device for continuous monitoring of the lungs of preterm born...

Cardeon’s entire shareholding in Neola Medical acquired by major shareholders

May 14, 2024

Press communication Lund, Sweden, May 14, 2024 This is a translation of the Swedish press release published 2024-05-14 Neola Medical AB (publ) announced today that Cardeon AB’s entire 2,358,805 shares in Neola Medical have been acquired by the company’s...

Successful results in completed Human Factors Validation Study with Neola® in the USA

Apr 18, 2024

Press communication Lund, Sweden, April 18, 2024 This is a translation of the Swedish press release published 2024-04-18 Neola Medical AB (publ) has completed the Human Factors Validation Study with Neola®, the company’s medical device for continuous lung...

Neola® wins silver medal and 25 000 USD in Stanford Pediatric Device Consortium (PDC) Accelerator Pitch Competition 2024

Mar 28, 2024

Press communication Lund, Sweden, March 28, 2024 This is a translation of the Swedish press release published 2024-03-28 Neola Medical’s product for lung monitoring of preterm born infants, Neola®, was selected by Stanford as one of the top ten most promising...

Neola Medical’s CEO shares more about the latest news in the spring investor letter

Mar 20, 2024

Press communication Lund, Sweden, March 20, 2024 This is a translation of the Swedish press release published 2024-03-20 The initial months of 2024 continue with intensive work and positive progress for Neola Medical in preparation for upcoming studies for market...

Neola Medical initiates Human Factors Validation Study in the USA ahead of FDA application for market approval

Feb 29, 2024

Press communication Lund, Sweden, February 29 This is a translation of the Swedish press release published 2024-02-29, 07.00 CET Neola Medical AB (publ) will commence a Human Factors Validation Study in March 2024 with Neola®, the company’s medical device for...